Study reveals effect of 3-n-butylphthalide on chronic ischemic stroke

NewsGuard 100/100 Score

The pathogenesis of vascular dementia induced by chronic cerebral ischemia is complex, mainly consisting of energy metabolism disorder, oxidative stress injury, neuronal apoptotic cell death and cholinergic nerve dysfunction. There is evidence that 3-n-butylphthalide can effectively antagonize acute ischemic stroke. However, the effect of 3-n-butylphthalide on chronic ischemic stroke remains unclear. Dr. Wanhong Zhao and her team, Institute of Basic Medical Sciences, Hubei University of Medicine, China performed a study and found that 3-n-butylphthalide improved neuronal morphology in cerebral cortex and hippocampus, alleviated oxidative stress caused by chronic cerebral ischemia, improved cholinergic function, and inhibited amyloid beta accumulation in rats subjected to chronic cerebral ischemia. Their findings were published in Neural Regeneration Research (Vol. 9, No. 7, 2014).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
What do we know about the mental health effects of chronic, slow-onset climate change?